What We're Reading: Groups Join ACA Defense; Stem Cell Treatments; Measles Surge
The American Medical Association and the AARP issue briefs in defense of the Affordable Care Act (ACA), while President Trump is delaying an ACA alternative until after the 2020; top hospitals offer unproven stem cell treatments; the measles outbreak hits a new high.
AMA, AARP Defend ACA While Trump Reportedly Punting ACA Alternative to 2020
The American Medical Association (AMA) and the AARP (formerly the American Association of Retired Persons) filed amicus briefs in the case of Texas v. United States, according to statements from the
Unproven Stem Cell Treatments on the Rise in Best Hospitals
A growing number of well-regarded hospitals are pursuing stem cell treatments and related therapies such as platelet injections, reported
Reported Cases of Measles Reach New High
More people have contracted measles in the first 3 months of 2019 than throughout the entire year of 2018,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025